Skip to main content

Off-patent Drugs Bill

Private Members' Bill (Ballot Bill)

Originated in the House of Commons, session 2015-16

Last updated: 13 May 2016 at 11:34

See full passage

Long title

A Bill to require the Secretary of State to seek licences for off-patent drugs in new indications; to require the National Institute for Health and Care Excellence to conduct technology appraisals for off-patent drugs in new indications; and for connected purposes.

Sponsor

Nick Thomas-Symonds
Labour
Torfaen

Current version of the Bill

5 November 2015
Commons

Bill passage

Bill started in the House of Commons
1st reading
Committee stage
Report stage
3rd reading
Bill in the House of Lords
1st reading
2nd reading
Committee stage
Report stage
3rd reading
Final stages
Consideration of amendments
Royal Assent
Key
Complete
In progress
Not applicable
Not yet reached